HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jun Yong Park Selected Research

wisteria lectin

1/2020Serum Wisteria floribunda agglutinin-positive human Mac-2 binding protein level predicts recurrence of hepatitis B virus-related hepatocellular carcinoma after curative resection.
1/2017Wisteria floribunda agglutinin-positive human Mac-2 binding protein predicts the risk of HBV-related liver cancer development.
1/2016Use of Wisteria Floribunda Agglutinin-Positive Human Mac-2 Binding Protein in Assessing Risk of Hepatocellular Carcinoma Due to Hepatitis B Virus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jun Yong Park Research Topics

Disease

113Hepatocellular Carcinoma (Hepatoma)
03/2024 - 09/2005
86Chronic Hepatitis B
09/2023 - 01/2008
55Fibrosis (Cirrhosis)
08/2023 - 04/2010
44Neoplasms (Cancer)
11/2023 - 09/2005
41Liver Cirrhosis (Hepatic Cirrhosis)
04/2024 - 02/2005
28Infections
01/2023 - 02/2005
16Hepatitis B
01/2022 - 04/2009
11Non-alcoholic Fatty Liver Disease
05/2023 - 10/2015
10Liver Neoplasms (Liver Cancer)
12/2021 - 09/2011
9Hypertension (High Blood Pressure)
02/2024 - 11/2015
9Thrombosis (Thrombus)
05/2022 - 09/2005
9Neoplasm Metastasis (Metastasis)
03/2020 - 09/2008
7Chronic Hepatitis C
01/2021 - 12/2009
6Disease Progression
03/2024 - 01/2008
6Ascites
01/2023 - 04/2010
6Liver Diseases (Liver Disease)
10/2022 - 07/2009
5Diabetes Mellitus
02/2024 - 11/2015
5Metabolic Syndrome (Dysmetabolic Syndrome X)
11/2023 - 01/2017
5End Stage Liver Disease
01/2021 - 09/2006
5Hemorrhage
01/2021 - 11/2005
5Hypoxia (Hypoxemia)
01/2017 - 09/2010
4Inflammation (Inflammations)
11/2023 - 07/2003
4Hepatitis
09/2023 - 07/2009
4Fatty Liver
05/2023 - 12/2020
4Vasculitis (Vasculitides)
01/2022 - 08/2018
4Insulin Resistance
06/2021 - 07/2003
4Liver Failure
01/2020 - 07/2009
3Dyslipidemias (Dyslipidemia)
05/2023 - 01/2017
3Viremia
01/2022 - 12/2019
3Type 2 Diabetes Mellitus (MODY)
01/2021 - 07/2016
3Hepatitis A (Hepatitis, Infectious)
01/2020 - 07/2011
3Virus Diseases (Viral Diseases)
01/2020 - 11/2010
2Varicose Veins (Varicose Vein)
08/2023 - 01/2013
2Alcoholic Fatty Liver
05/2023 - 01/2022
2Peritonitis
01/2023 - 09/2009

Drug/Important Bio-Agent (IBA)

61Antiviral Agents (Antivirals)IBA
09/2023 - 08/2010
31entecavirFDA Link
01/2023 - 01/2009
26DNA (Deoxyribonucleic Acid)IBA
09/2023 - 03/2008
22Sorafenib (BAY 43-9006)FDA Link
03/2024 - 09/2011
22Alanine Transaminase (SGPT)IBA
01/2023 - 03/2009
22Tenofovir (Viread)FDA Link
01/2022 - 09/2014
21Hepatitis B e AntigensIBA
09/2023 - 01/2008
19Lamivudine (Epivir)FDA Link
01/2020 - 01/2008
14Serum AlbuminIBA
04/2024 - 03/2015
14Hepatitis B Surface Antigens (HBsAg)FDA Link
09/2023 - 02/2005
14alpha-Fetoproteins (alpha-Fetoprotein)IBA
01/2021 - 11/2009
12Aspartate Aminotransferases (Aspartate Transaminase)IBA
01/2023 - 04/2010
11BilirubinIBA
08/2023 - 07/2009
10acarboxyprothrombin (PIVKA)IBA
01/2021 - 01/2012
10adefovirIBA
01/2020 - 01/2009
9Fetal Proteins (Fetoprotein)IBA
01/2020 - 01/2011
8Biomarkers (Surrogate Marker)IBA
01/2022 - 06/2012
8lipoarabinomannan (LAM)IBA
01/2020 - 11/2010
7AlbuminsIBA
08/2023 - 01/2019
7Proteins (Proteins, Gene)FDA Link
01/2022 - 06/2010
5AntigensIBA
01/2022 - 05/2012
5InterferonsIBA
11/2020 - 01/2013
5Prothrombin (Factor II)IBA
09/2019 - 01/2012
5Tumor Biomarkers (Tumor Markers)IBA
01/2016 - 07/2012
4Antineutrophil Cytoplasmic Antibodies (ANCA)IBA
01/2022 - 08/2018
4RNA (Ribonucleic Acid)IBA
01/2022 - 02/2015
4Transaminases (Aminotransferases)IBA
04/2021 - 07/2009
4Ribavirin (Virazole)FDA LinkGeneric
11/2020 - 12/2009
4Glucose (Dextrose)FDA LinkGeneric
05/2020 - 01/2013
4CytokinesIBA
01/2020 - 10/2012
4Fluorouracil (Carac)FDA LinkGeneric
01/2013 - 07/2007
3lenvatinibIBA
03/2024 - 05/2021
3Insulin (Novolin)FDA Link
11/2023 - 07/2016
3Choline (Choline Chloride)IBA
11/2023 - 01/2022
3Ezetimibe (Zetia)FDA Link
05/2023 - 12/2020
3Anti-Bacterial Agents (Antibiotics)IBA
01/2023 - 09/2009
3nasIBA
01/2022 - 06/2014
3Aspartic Acid (Aspartate)FDA Link
01/2022 - 03/2009
3CholesterolIBA
11/2021 - 01/2020
3Indicators and Reagents (Reagents)IBA
10/2021 - 09/2011
3wisteria lectinIBA
01/2020 - 01/2016
3Carrier Proteins (Binding Protein)IBA
01/2020 - 01/2016
3TelbivudineFDA Link
01/2020 - 01/2013
3Vitamin KFDA Link
09/2019 - 07/2012
3Rituximab (Mabthera)FDA Link
10/2018 - 01/2017
3thiamine triphosphorate (TTP)IBA
01/2018 - 04/2015
3NucleosidesIBA
01/2018 - 01/2016
3Interleukin-8 (Interleukin 8)IBA
01/2017 - 04/2014
3Small Interfering RNA (siRNA)IBA
04/2014 - 09/2010
3adefovir dipivoxil (Hepsera)FDA Link
03/2013 - 01/2009
3Cisplatin (Platino)FDA LinkGeneric
04/2011 - 07/2007
2CateninsIBA
11/2023 - 01/2021
2NivolumabIBA
01/2023 - 03/2020
2Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
01/2022 - 06/2021
2Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2022 - 01/2019
2FumaratesIBA
01/2022 - 01/2019
2Rosuvastatin Calcium (Crestor)FDA Link
01/2022 - 12/2020
2((1- ((2- amino- 9H- purin- 9- yl)methyl)cyclopropyl)oxy)methylphosphonic acid dipivoxylIBA
12/2021 - 05/2020

Therapy/Procedure

86Therapeutics
03/2024 - 07/2009
20Drug Therapy (Chemotherapy)
10/2021 - 08/2002
13Liver Transplantation
10/2022 - 09/2006
7Chemoradiotherapy
05/2022 - 01/2011
5Radiotherapy
06/2023 - 12/2010
4Radiofrequency Ablation
09/2020 - 01/2015
2Duration of Therapy
01/2023 - 11/2020